|
17
|
124
|
7yldA |
Two monobodies recognizing the conserved epitopes of sars-cov-2 n antigen applicable to the broad covid-19 diagnosis |
|
32
|
210
|
8tgoC |
Crystal structure of the bg505 triple tandem trimer gp140 hiv-1 env in complex with pgt124 and 35o22 |
|
19
|
130
|
8tgoO |
Crystal structure of the bg505 triple tandem trimer gp140 hiv-1 env in complex with pgt124 and 35o22 |
|
79
|
471
|
8tgoG |
Crystal structure of the bg505 triple tandem trimer gp140 hiv-1 env in complex with pgt124 and 35o22 |
|
36
|
264
|
8tgoD |
Crystal structure of the bg505 triple tandem trimer gp140 hiv-1 env in complex with pgt124 and 35o22 |
|
84
|
418
|
8sgnG |
Crystal structure of epstein-barr virus glycoprotein 350 (gp350) in complex with cy651h02, a monoclonal antibody isolated from macaques immunized with a gp350 nanoparticle vaccine |
|
39
|
220
|
8sgnH |
Crystal structure of epstein-barr virus glycoprotein 350 (gp350) in complex with cy651h02, a monoclonal antibody isolated from macaques immunized with a gp350 nanoparticle vaccine |
|
71
|
424
|
8sicE |
Crystal structure of epstein-barr virus glycoprotein 350 (gp350) in complex with cy137c02, a monoclonal antibody isolated from macaques immunized with a gp350 nanoparticle vaccine |
|
32
|
222
|
8sicA |
Crystal structure of epstein-barr virus glycoprotein 350 (gp350) in complex with cy137c02, a monoclonal antibody isolated from macaques immunized with a gp350 nanoparticle vaccine |
|
33
|
145
|
8tgoB |
Crystal structure of the bg505 triple tandem trimer gp140 hiv-1 env in complex with pgt124 and 35o22 |
|
47
|
214
|
8sgnL |
Crystal structure of epstein-barr virus glycoprotein 350 (gp350) in complex with cy651h02, a monoclonal antibody isolated from macaques immunized with a gp350 nanoparticle vaccine |
|
42
|
215
|
8sicB |
Crystal structure of epstein-barr virus glycoprotein 350 (gp350) in complex with cy137c02, a monoclonal antibody isolated from macaques immunized with a gp350 nanoparticle vaccine |
|
94
|
491
|
8v7oA |
Fab fragment of human mab #58 in complex with computationally optimized broadly reactive h1 influenza hemagglutinin x6 |
|
16
|
123
|
8v7oH |
Fab fragment of human mab #58 in complex with computationally optimized broadly reactive h1 influenza hemagglutinin x6 |
|
12
|
109
|
8v7oL |
Fab fragment of human mab #58 in complex with computationally optimized broadly reactive h1 influenza hemagglutinin x6 |
|
218
|
1125
|
8vyeE |
Sars-cov-2 s (c.37 lambda variant) plus s309, s2l20, and s2x303 fabs |
|
26
|
126
|
8vygA |
Sars-cov-2 s rbd (c.37 lambda variant) plus s309 fab, local refinement |
|
16
|
107
|
8vyeC |
Sars-cov-2 s (c.37 lambda variant) plus s309, s2l20, and s2x303 fabs |
|
37
|
194
|
8vygR |
Sars-cov-2 s rbd (c.37 lambda variant) plus s309 fab, local refinement |
|
15
|
125
|
8vyeH |
Sars-cov-2 s (c.37 lambda variant) plus s309, s2l20, and s2x303 fabs |
|
15
|
105
|
8vyfL |
Sars-cov-2 s ntd (c.37 lambda variant) plus s2l20 and s2x303 fabs, local refinement |
|
44
|
285
|
8vyfA |
Sars-cov-2 s ntd (c.37 lambda variant) plus s2l20 and s2x303 fabs, local refinement |
|
27
|
121
|
8vyfB |
Sars-cov-2 s ntd (c.37 lambda variant) plus s2l20 and s2x303 fabs, local refinement |
|
25
|
105
|
8vyfC |
Sars-cov-2 s ntd (c.37 lambda variant) plus s2l20 and s2x303 fabs, local refinement |
|
24
|
106
|
8vygB |
Sars-cov-2 s rbd (c.37 lambda variant) plus s309 fab, local refinement |
|
16
|
105
|
8vyeL |
Sars-cov-2 s (c.37 lambda variant) plus s309, s2l20, and s2x303 fabs |
|
15
|
106
|
8vyeD |
Sars-cov-2 s (c.37 lambda variant) plus s309, s2l20, and s2x303 fabs |
|
14
|
119
|
8vyfH |
Sars-cov-2 s ntd (c.37 lambda variant) plus s2l20 and s2x303 fabs, local refinement |
|
15
|
121
|
8vyeB |
Sars-cov-2 s (c.37 lambda variant) plus s309, s2l20, and s2x303 fabs |
|
16
|
126
|
8vyeA |
Sars-cov-2 s (c.37 lambda variant) plus s309, s2l20, and s2x303 fabs |
|
10
|
125
|
8gauH |
Structure of human nds.1 fab and 1g01 fab in complex with influenza virus neuraminidase from a/indiana/10/2011 (h3n2v) |
|
74
|
387
|
8gavA |
Structure of human nds.3 fab in complex with influenza virus neuraminidase from a/darwin/09/2021 (h3n2) |
|
11
|
108
|
8gauN |
Structure of human nds.1 fab and 1g01 fab in complex with influenza virus neuraminidase from a/indiana/10/2011 (h3n2v) |
|
14
|
108
|
8gatN |
Structure of human nds.1 fab and 1g01 fab in complex with influenza virus neuraminidase from a/indiana/10/2011 (h3n2v), based on consensus cryo-em map with only fab 1g01 resolved |
|
16
|
107
|
8gavL |
Structure of human nds.3 fab in complex with influenza virus neuraminidase from a/darwin/09/2021 (h3n2) |
|
15
|
127
|
8gatM |
Structure of human nds.1 fab and 1g01 fab in complex with influenza virus neuraminidase from a/indiana/10/2011 (h3n2v), based on consensus cryo-em map with only fab 1g01 resolved |
|
70
|
386
|
8gatA |
Structure of human nds.1 fab and 1g01 fab in complex with influenza virus neuraminidase from a/indiana/10/2011 (h3n2v), based on consensus cryo-em map with only fab 1g01 resolved |
|
67
|
386
|
8gauA |
Structure of human nds.1 fab and 1g01 fab in complex with influenza virus neuraminidase from a/indiana/10/2011 (h3n2v) |
|
10
|
127
|
8gauM |
Structure of human nds.1 fab and 1g01 fab in complex with influenza virus neuraminidase from a/indiana/10/2011 (h3n2v) |
|
15
|
105
|
8gauL |
Structure of human nds.1 fab and 1g01 fab in complex with influenza virus neuraminidase from a/indiana/10/2011 (h3n2v) |
|
16
|
122
|
8gavH |
Structure of human nds.3 fab in complex with influenza virus neuraminidase from a/darwin/09/2021 (h3n2) |
|
207
|
1134
|
8g77A |
Sars-cov-2 spike/nb6 complex |
|
206
|
1134
|
8g76A |
Sars-cov-2 spike/nb5 complex |
|
200
|
1134
|
8g70A |
Sars-cov-2 spike/nanobody mixture complex |
|
23
|
127
|
8g7cE |
Local refinement of sars-cov-2 spike/nb4 complex with 2 rbds up and 3 nb4 bound |
|
17
|
118
|
8g78E |
Local refinement of sars-cov-2 spike/nanobody mixture complex around ntd |
|
12
|
118
|
8g70F |
Sars-cov-2 spike/nanobody mixture complex |
|
22
|
127
|
8g70N |
Sars-cov-2 spike/nanobody mixture complex |
|
18
|
115
|
8g7bC |
Sars-cov-2 spike/nb3 complex with 1 rbd up and 2 nb3 (local refinement) |
|
16
|
115
|
8g79M |
Local refinement of sars-cov-2 spike/nanobody mixture complex around rbd |
